Certain information in this document has been omitted from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. Patent and Technology License AgreementPatent and Technology License Agreement • May 14th, 2020 • Genprex, Inc. • Pharmaceutical preparations • Texas
This Patent and Technology License Agreement (“Agreement”) is made, effective on the date fully executed by both Parties (the “Effective Date”), by and between The Board of Regents (“Board”) of The University of Texas System (“System”), an agency of the State of Texas, whose address is 210 West 7th Street, Austin, Texas 78701, on behalf of The University of Texas M. D. Anderson Cancer Center (“MD Anderson”), a member institution of System, and Genprex, Inc., having a place of business at Dell Medical School, Health Discovery Building, 1601 Trinity Street, Suite 3.322, Austin, Texas 78712 (“Licensee”). Board and Licensee are each referred to herein as a “Party” and collectively as the “Parties.” In consideration of the mutual covenants and promises herein contained, the Parties agree as follows:
